Chemicals & Advanced Materials Global On demand · 24-48h

Global Marine Derived Protein Market Strategic Research Report

Global Marine Derived Protein Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Marine Derived Protein Market
$8.07B2025
6.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Fish Collagen Peptides, Fish Protein Hydrolysate, Marine Bioactive Peptides, Seaweed Protein, Others

By Application: Nutraceuticals and Dietary Supplements, Functional Foods and Beverages, Cosmetics and Personal Care, Pharmaceuticals, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Hofseth BioCare ASA, Copalis Sea Solutions, Weishardt Group, Nippi Collagen, Jiaji Peptide, Thai Union Ingredients, Athos Collagen Pvt. Ltd, Scanbio Marine Group, Hainan Huayan Collagen Technology, Beijing Semnl Biotechnology, Yantai Jiahui Marine Biotech, Dongwon F&B, Hainan Pure Peptide Technology, Shandong Hailongyuan Bio‑tech, Zhejiang Pingtairong Biotech, Marin Techno, Primapharm / Amar Aquatic, Nizona Marine Products, Aquaproducts, Japfa Prime Seafood, Vietfeeds, Mowi ASA, Pelagia, Dongwon Industries, Iizuka Shoukai

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 149 pages
Market size 2025
$8.07B
Billion USD
Forecast CAGR
6.4%
2025-2032
Forecast 2032
$12.5B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Marine Derived Protein market size is predicted to grow from US$ 8,073 million in 2025 to US$ 12,411 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

Marine derived proteins refer to proteins, protein hydrolysates, and bioactive peptides extracted from marine biomass including fish, shellfish, crustaceans and algae, using enzymatic hydrolysis, fermentation, acid/alkali extraction, and membrane filtration technologies. In 2025,global marine derived protein production reached approximately 117,889 ton, with an average global market price of around USD 70,000 per ton. A factory gross profit of USD 17,500 per ton with 25% gross margin. A single line full machine capacity production is around 2,000 ton per line per year. The upstream is dependent on raw fish, processing chemicals and enzymes. The downstream demand is concentrated in nutraceuticals,functonal food and beverages and cosmetics and personal care. fish collagen peptides use. Marine collagen peptides are added into protein drinks consumed by athletes to support connective tissue recovery. China market is driven by domestic health supplement consumption and growing functional food market. US market is driven by large nutraceutical market and high collagen consumption

Global key Marine Derived Protein players cover Hofseth BioCare ASA, Copalis Sea Solutions, Weishardt Group, Nippi Collagen, Jiaji Peptide, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Marine Derived Protein market?

What factors are driving Marine Derived Protein market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Marine Derived Protein market opportunities vary by end market size?

How does Marine Derived Protein break out by Type, by Application?

This report presents a comprehensive overview of the global Marine Derived Protein market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Fish Collagen Peptides
  • Fish Protein Hydrolysate
  • Marine Bioactive Peptides
  • Seaweed Protein
  • Others

Segment by Production Process

  • Enzymatic Hydrolysis
  • Alkali Extraction
  • Membrane Filtration Fractionation
  • Spray Drying
  • Others

Segment by Solubility Grade

  • Standard Solubility (≥80-90%)
  • High Solubility (>95%)
  • Cold Water Soluble (Instant)
  • Others

Segment by Application

  • Nutraceuticals and Dietary Supplements
  • Functional Foods and Beverages
  • Cosmetics and Personal Care
  • Pharmaceuticals
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Marine Derived Protein market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Nutraceuticals and Dietary Supplements, Functional Foods and Beverages, Cosmetics and Personal Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Marine Derived Protein Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$8.07B
2025
Forecast
$12.5B
2032
CAGR
6.4%
2025–2032
Régions
5
global
Key companies
Hofseth BioCare ASACopalis Sea SolutionsWeishardt GroupNippi CollagenJiaji PeptideThai Union IngredientsAthos Collagen Pvt. LtdScanbio Marine Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Fish Collagen PeptidesFish Protein HydrolysateMarine Bioactive PeptidesSeaweed ProteinOthers
By Application
Nutraceuticals and Dietary SupplementsFunctional Foods and BeveragesCosmetics and Personal CarePharmaceuticalsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Fish Collagen Peptides
  • 3.1.3 Fish Protein Hydrolysate
  • 3.1.4 Marine Bioactive Peptides
  • 3.1.5 Seaweed Protein
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Nutraceuticals and Dietary Supplements
  • 4.1.3 Functional Foods and Beverages
  • 4.1.4 Cosmetics and Personal Care
  • 4.1.5 Pharmaceuticals
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Hofseth BioCare ASA
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Copalis Sea Solutions
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Weishardt Group
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nippi Collagen
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Jiaji Peptide
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Thai Union Ingredients
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Athos Collagen Pvt. Ltd
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Scanbio Marine Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Hainan Huayan Collagen Technology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Beijing Semnl Biotechnology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Yantai Jiahui Marine Biotech
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Dongwon F&B
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Hainan Pure Peptide Technology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shandong Hailongyuan Bio‑tech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Zhejiang Pingtairong Biotech
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Marin Techno
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Primapharm / Amar Aquatic
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Nizona Marine Products
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Aquaproducts
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Japfa Prime Seafood
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Vietfeeds
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Mowi ASA
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Pelagia
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Dongwon Industries
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Iizuka Shoukai
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Marine Derived Protein market?
The global Marine Derived Protein market is estimated at US$ 8.07 billion in 2025 (base year) and is projected to reach US$ 12.41 billion by 2032.
What is the forecast CAGR for the Marine Derived Protein market?
The market is expected to grow at a CAGR of 6.4% from 2026 to 2032, expanding from US$ 8.07 billion in 2025 to US$ 12.41 billion in 2032, roughly 1.5 times its base-year value.
What is Marine Derived Protein?
Marine derived proteins refer to proteins, protein hydrolysates, and bioactive peptides extracted from marine biomass including fish, shellfish, crustaceans and algae, using enzymatic hydrolysis, fermentation, acid/alkali extraction, and membrane filtration technologies. In 2025,global marine derived protein production reached approximately 117,889 ton, with an average global market price of around USD 70,000 per ton. A factory gross profit of USD 17,500 per ton with 25% gross margin.
What are the main segments of the Marine Derived Protein market by type?
By type, the market is segmented into Fish Collagen Peptides, Fish Protein Hydrolysate, Marine Bioactive Peptides, Seaweed Protein and Others.
Which applications drive demand in the Marine Derived Protein market?
Key applications covered include Nutraceuticals and Dietary Supplements, Functional Foods and Beverages, Cosmetics and Personal Care, Pharmaceuticals and Others.
Who are the key players in the Marine Derived Protein market?
Key players profiled include Hofseth BioCare ASA, Copalis Sea Solutions, Weishardt Group, Nippi Collagen, Jiaji Peptide, Thai Union Ingredients, Athos Collagen Pvt. Ltd and Scanbio Marine Group, among 25 companies covered in total.
Which regions and countries are covered for Marine Derived Protein?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Marine Derived Protein market?
What factors are driving Marine Derived Protein market growth, globally and by region?
Who should buy the Marine Derived Protein market report?
The report is intended for manufacturers and solution providers, distributors and end users in Nutraceuticals and Dietary Supplements, Functional Foods and Beverages and Cosmetics and Personal Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Marine Derived Protein market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.